Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Inga Mandac, Rogulj"'
Autor:
Theo de Witte, Luca Malcovati, Pierre Fenaux, David Bowen, Argiris Symeonidis, Moshe Mittelman, Reinhard Stauder, Guillermo Sanz, Jaroslav Čermák, Saskia Langemeijer, Eva Hellström-Lindberg, Ulrich Germing, Mette Skov Holm, Krzysztof Mądry, Aurelia Tatic, António Medina Almeida, Aleksandar Savic, Inga Mandac Rogulj, Raphael Itzykson, Marlijn Hoeks, Hege Gravdahl Garelius, Dominic Culligan, Ioannis Kotsianidis, Lionel Ades, Arjan A. Van de Loosdrecht, Corine van Marrewijk, Ge Yu, Simon Crouch, Alex Smith
Publikováno v:
Haematologica, Vol 105, Iss 11 (2020)
Externí odkaz:
https://doaj.org/article/e9e7fd1f5ec34527861a53693a196e06
Autor:
Martina Bogeljić Patekar, Vibor Milunović, Karla Mišura Jakobac, Dražen Perica, Inga Mandac Rogulj, Marin Kursar, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Publikováno v:
Acta Clinica Croatica, Vol 57., Iss 3., Pp 542-553 (2018)
The aim of this review is to present data on bendamustine, a non-cross resistant alkylating agent, alone or in combination for treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Bendamustine is currently approved for ritu
Externí odkaz:
https://doaj.org/article/a532d7dede5040d49da04c819b38aa99
Autor:
Vibor Milunović, Martina Bogeljić Patekar, Karla Mišura Jakubac, Inga Mandac Rogulj, Delfa Radić-Krišto, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 1., Pp 143-156 (2017)
Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to these hematologic malignancies in the last decade. The main aim of this review is to present da
Externí odkaz:
https://doaj.org/article/56a6185676fe49db91e004668b948a8e
Autor:
Inga Mandac Rogulj, Vibor Milunović, Delfa Radić-Krišto, Karla Mišura Jakobac, Slobodanka Ostojić Kolonić, Marko Martinović
Publikováno v:
Expert Review of Hematology. 13:771-779
Introduction: Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries occurring typically in elderly patients. These patients often present with comorbidities limiting treatment options. During the last decade, the treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::549545f212fe4be40202bc8907dd52b9
https://doi.org/10.1080/17474086.2020.1775575
https://doi.org/10.1080/17474086.2020.1775575
Autor:
Inga Mandac-Rogulj, Duška Petranović, Marijo Vodanović, Jelena Roganović, Vlatko Pejša, Toni Valković, Ivo Radman, Igor Aurer, Slobodanka Ostojić Kolonić, Rajko Kusec
Publikováno v:
Liječnički vjesnik. 141:1-13
Iron deficiency anemia (IDA) is an important public health problem. Almost 30% of the world’s population (> 2 billion) has iron deficiency (ID) with or without anemia. Treatment of IDA requires teamwork. It is important to treat anemia and the unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9a31c09296b82db8745c8deb8c26527
https://doi.org/10.26800/lv-141-1-2-1
https://doi.org/10.26800/lv-141-1-2-1
Autor:
Slobodanka Ostojić Kolonić, Ika Kardum-Skelin, Suzana Katalenić Simon, Mia Šunjić Stakor, Delfa Radić Krišto, Inga Mandac Rogulj, Marina Pažur, Gordana Kaić, Biljana Jelić Puškarić
Publikováno v:
Liječnički vjesnik. 141:220-225
Diagnostic category of MDS/MPN includes clonal hematopoietic neoplasms, which show the concomitant clinical, laboratory and/or morphologic features of both myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN) at the time of diagnosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::497b67caf205ddb7c718e76a73ae7a6a
https://doi.org/10.26800/lv-141-7-8-28
https://doi.org/10.26800/lv-141-7-8-28
Autor:
Inga Mandac Rogulj, Ika Kardum-Skelin, Njetocka Gredelj-Simec, Sanja Davidović Mrsić, Dražen Perica, Karla Mišura Jakobac, Anita Škrtić, Vibor Milunović, Slobodanka Ostojić Kolonić
Publikováno v:
Liječnički vjesnik. 141:238-246
Introduction: Myelodysplastic syndrome (MDS) is one of the most common myeloid neoplasms of elderly characterized by cytopenias and limited therapeutic options. The main aim of this retrospective single-center study was to examine the value of classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9d66d5fab4deb6f4e76d7662a4af0c1
https://doi.org/10.26800/lv-141-7-8-31
https://doi.org/10.26800/lv-141-7-8-31
Autor:
Aleksandar Savic, Simon Crouch, Guillermo Sanz, Alex Smith, Moshe Mittelman, Hege Garelius, Theo de Witte, Saskia Langemeijer, Aurelia Tatic, Ioannis Kotsianidis, Eva Hellström-Lindberg, Ulrich Germing, Mette Holm, Luca Malcovati, Corine van Marrewijk, Jaroslav Cermak, Arjan A. van de Loosdrecht, Dominic Culligan, Inga Mandac Rogulj, Lionel Ades, Ge Yu, David T. Bowen, Pierre Fenaux, Argiris Symeonidis, Antonio Almeida, Raphael Itzykson, Krzysztof Mądry, Marlijn Hoeks, Reinhard Stauder
Publikováno v:
Haematologica
Haematologica, 105, 11, pp. 2516-2523
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Haematologica, 105, 2516-2523
De Witte, T, Malcovati, L, Fenaux, P, Bowen, D, Symeonidis, A, Mittelman, M, Stauder, R, Sanz, G, Čermák, J, Langemeijer, S, Hellström-Lindberg, E, Germing, U, Skov Holm, M, Mądry, K, Tatic, A, Medina Almeida, A, Savic, A, Mandac Rogulj, I, Itzykson, R, Hoeks, M, Gravdahl Garelius, H, Culligan, D, Kotsianidis, I, Ades, L, Van de Loosdrecht, A A, Van Marrewijk, C, Yu, G, Crouch, S & Smith, A 2020, ' Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective ', Haematologica, vol. 105, no. 11 . https://doi.org/10.3324/haematol.2020.266817
de Witte, T, Malcovati, L, Fenaux, P, Bowen, D, Symeonidis, A, Mittelman, M, Stauder, R, Sanz, G, Čermák, J, Langemeijer, S, Hellström-Lindberg, E, Germing, U, Skov Holm, M, Mądry, K, Tatic, A, Medina Almeida, A, Savic, A, Mandac Rogulj, I, Itzykson, R, Hoeks, M, Gravdahl Garelius, H, Culligan, D, Kotsianidis, I, Ades, L, van de Loosdrecht, A A, van Marrewijk, C, Yu, G, Crouch, S & Smith, A 2020, ' Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective ', Haematologica, vol. 105, no. 11, pp. 2516-2523 . https://doi.org/10.3324/haematol.2020.266817
Haematologica, 105, 11, pp. 2516-2523
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Haematologica, 105, 2516-2523
De Witte, T, Malcovati, L, Fenaux, P, Bowen, D, Symeonidis, A, Mittelman, M, Stauder, R, Sanz, G, Čermák, J, Langemeijer, S, Hellström-Lindberg, E, Germing, U, Skov Holm, M, Mądry, K, Tatic, A, Medina Almeida, A, Savic, A, Mandac Rogulj, I, Itzykson, R, Hoeks, M, Gravdahl Garelius, H, Culligan, D, Kotsianidis, I, Ades, L, Van de Loosdrecht, A A, Van Marrewijk, C, Yu, G, Crouch, S & Smith, A 2020, ' Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective ', Haematologica, vol. 105, no. 11 . https://doi.org/10.3324/haematol.2020.266817
de Witte, T, Malcovati, L, Fenaux, P, Bowen, D, Symeonidis, A, Mittelman, M, Stauder, R, Sanz, G, Čermák, J, Langemeijer, S, Hellström-Lindberg, E, Germing, U, Skov Holm, M, Mądry, K, Tatic, A, Medina Almeida, A, Savic, A, Mandac Rogulj, I, Itzykson, R, Hoeks, M, Gravdahl Garelius, H, Culligan, D, Kotsianidis, I, Ades, L, van de Loosdrecht, A A, van Marrewijk, C, Yu, G, Crouch, S & Smith, A 2020, ' Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective ', Haematologica, vol. 105, no. 11, pp. 2516-2523 . https://doi.org/10.3324/haematol.2020.266817
Available evidence suggests that in most patients with LR-MDS the risk of death is not related to disease progression but is mainly attributable to non-leukemic death. 2,17 In addition, a proportion of these patients have prolonged survival that prec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce2855a89c0f32b85d151461ed3da512
https://eprints.whiterose.ac.uk/165855/1/10022_Article_Text_73186_1_10_20200921_1_.pdf
https://eprints.whiterose.ac.uk/165855/1/10022_Article_Text_73186_1_10_20200921_1_.pdf
Autor:
Dean Mileta, Ingrid Prkačin, Ana Planinc Peraica, Gordana Cavrić, Inga Mandac Rogulj, Višnja Mandac Bajan
Publikováno v:
Liječnički vjesnik. 141:247-249
Myelodysplastic syndromes (MDS) are a group of clonal disorders arising from hematopoietic stem cells and are generally characterized by inefficient hematopoiesis and dysplasia. The International Prognostic Scoring Sytem (IPSS) is an important standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cedb55465a84b71a23df5b0dfcf9b09
https://doi.org/10.26800/lv-141-7-8-32
https://doi.org/10.26800/lv-141-7-8-32
Autor:
Ana Reschner, Delfa Radić-Krišto, Slobodanka Ostojić Kolonić, Inga Mandac Rogulj, Gordana Kaić, Marin Kursar, Marko Martinović, Morana Kosanović-Bajić, Ana Planinc-Peraica
Publikováno v:
Liječnički vjesnik. 141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d5f3de95ead574f4c841c5ae0e9b6ae
https://doi.org/10.26800/lv-141-9-10-39
https://doi.org/10.26800/lv-141-9-10-39